<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> has long been appreciated to play a critical role in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development and maintenance </plain></SENT>
<SENT sid="1" pm="."><plain>Among the mechanisms involved in coordinating the initiation and resolution of <z:mp ids='MP_0001845'>inflammation</z:mp> are those responsible for modifying <z:chebi fb="2" ids="33699">mRNA</z:chebi> stability and/or translation </plain></SENT>
<SENT sid="2" pm="."><plain>Several studies have linked the <z:chebi fb="40" ids="33697">RNA</z:chebi>-binding protein HuR, which increases <z:chebi fb="2" ids="33699">mRNA</z:chebi> stability, with <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, in this issue of the JCI, Yiakouvaki et al. compellingly demonstrate in mice that increased HuR activity in myeloid cells has a protective role in the <z:hpo ids='HP_0003674'>onset</z:hpo> of pathologic <z:mp ids='MP_0001858'>intestinal inflammation</z:mp> (i.e., <z:hpo ids='HP_0002583'>colitis</z:hpo>) and <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (CAC) </plain></SENT>
<SENT sid="4" pm="."><plain>These observations highlight the need to understand the roles of HuR in distinct cell populations in vivo and suggest that enhancing HuR activity may be of clinical benefit in protecting against pathologic <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>